Mandatory notification of trade
16 June, 2010, Lysaker, Norway: Primary insider, Sverre Sondbø, board member and process development manager in Pronova BioPharma ASA, today bought 2,500 shares in the company.
The shares were bought at an average share price of NOK 13.65. Total number of shares held by Mr Sondbø after the purchase is 9,500.
This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)